X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
β3-adrenergic receptor (127) 127
obesity (97) 97
animals (58) 58
male (46) 46
humans (36) 36
polymorphism (34) 34
mice (32) 32
adrenergic receptor (31) 31
female (26) 26
uncoupling protein 1 (24) 24
β3 adrenergic receptor (23) 23
β3-adrenergic receptor gene (23) 23
receptors, adrenergic, beta-3 - metabolism (22) 22
brown adipose tissue (20) 20
insulin resistance (20) 20
receptors, adrenergic, beta-3 - genetics (20) 20
uncoupling protein (19) 19
diabetes (18) 18
rats (18) 18
adrenergic beta-3 receptor agonists - pharmacology (17) 17
biochemistry & molecular biology (17) 17
leptin (16) 16
mice, inbred c57bl (16) 16
adipose tissue (15) 15
adrenergic receptors (14) 14
beta 3-adrenergic receptor (14) 14
receptor (14) 14
thermogenesis (14) 14
adult (13) 13
endocrinology & metabolism (13) 13
β3-adrenergic receptors (13) 13
adipose tissue - metabolism (12) 12
agonist (12) 12
middle aged (12) 12
β3‐adrenergic receptor (12) 12
aged (11) 11
brown adipose-tissue (11) 11
cell biology (11) 11
metabolism (11) 11
obesity - metabolism (11) 11
lipolysis (10) 10
oxidative stress (10) 10
β3-adrenergic receptor agonist (10) 10
adipocytes (9) 9
adipose tissue, brown - metabolism (9) 9
body mass index (9) 9
fat (9) 9
heart failure (9) 9
insulin (9) 9
trp64arg polymorphism (9) 9
type 2 diabetes (9) 9
association (8) 8
beta-adrenergic receptor (8) 8
biophysics (8) 8
dioxoles - pharmacology (8) 8
hypertension (8) 8
japan (8) 8
metabolic syndrome (8) 8
nitric oxide (8) 8
pharmacology & pharmacy (8) 8
physiology (8) 8
adrenergic beta-agonists - pharmacology (7) 7
blotting, western (7) 7
energy intake (7) 7
energy metabolism (7) 7
gene (7) 7
gene expression (7) 7
genotype (7) 7
internal medicine (7) 7
nutrition & dietetics (7) 7
obesity - genetics (7) 7
rat (7) 7
rats, wistar (7) 7
trp64arg mutation (7) 7
β (7) 7
β3-adrenergic (7) 7
activation (6) 6
adipocytes - cytology (6) 6
adipose tissue, brown - drug effects (6) 6
adrenergic beta-3 receptor antagonists - pharmacology (6) 6
body weight (6) 6
body weight - drug effects (6) 6
diabetes mellitus (6) 6
disease models, animal (6) 6
energy expenditure (6) 6
ethanolamines - pharmacology (6) 6
exercise (6) 6
expression (6) 6
gene frequency (6) 6
genetic polymorphism (6) 6
genetics (6) 6
ion channels (6) 6
medicine & public health (6) 6
mice, knockout (6) 6
mitochondrial proteins (6) 6
mutation (6) 6
original (6) 6
overactive bladder (6) 6
polymerase chain reaction (6) 6
polymorphism, genetic (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert Opinion on Investigational Drugs, ISSN 1744-7658, 2006, Volume 15, Issue 8, pp. 897 - 915
Obesity is a major public health concern and environmental factors are involved in its development. The hypothalamus is a primary site for the integration of... 
adiponectin | glucagon-like peptide-1 | cholecystokinin | peroxisome proliferator-activated receptor-γ | melanin-concentrating hormone | 3-36 | leptin | ciliary neurotrophic factor | oxyntomodulin | cannabinoid-1 receptor antagonists | ghrelin | peroxisome proliferator-activated receptor-β/δ | somatostatin | growth hormone | peptide YY | bupropion | dopamine | adrenergic receptor agonists | obesity | lipase inhibitors | melanocortin | topiramate | β3-adrenergic receptor agonists | peptide YY3-36, peroxisome proliferator-activated receptor-γ | Obesity | Topiramate | Dopamine | Peroxisome proliferator-activated receptor-β/δ | Peroxisome proliferator-activated receptor-γ | Melanocortin | Peptide YY | Ciliary neurotrophic factor | Oxyntomodulin | Adiponectin | Glucagon-like peptide-1 | Bupropion | Lipase inhibitors | Ghrelin | Melanin-concentrating hormone | Leptin | Cannabinoid-1 receptor antagonists | Cholecystokinin | Somatostatin | Growth hormone | antagonists | BODY-WEIGHT GAIN | beta-adrenergic receptor agonists | CB1 CANNABINOID RECEPTOR | cannabinoid-1 receptor | PHARMACOLOGY & PHARMACY | CARDIOVASCULAR RISK-FACTORS | BINGE-EATING DISORDER | peptide YY3-36 | DIET-INDUCED OBESITY | MELANOCORTIN-1 AND-4 RECEPTORS | peroxisome proliferator-activated receptor-beta/delta | peroxisome proliferator-activated receptor-gamma | INCREASES INSULIN SENSITIVITY | REDUCES FOOD-INTAKE | Recombinant Proteins - therapeutic use | Serotonin 5-HT1 Receptor Agonists | Body Weight | Drugs, Investigational - pharmacology | Obesity - drug therapy | Receptors, G-Protein-Coupled - metabolism | Humans | Receptor, Serotonin, 5-HT2C - metabolism | Drugs, Investigational - therapeutic use | Receptors, Neuropeptide Y - metabolism | Receptor, Melanocortin, Type 4 - metabolism | Anti-Obesity Agents - therapeutic use | Serotonin Receptor Agonists - pharmacology | Receptor, Serotonin, 5-HT1B - metabolism | Receptors, Neuropeptide Y - antagonists & inhibitors | Leptin - pharmacology | Hypothalamus - drug effects | Receptors, Ghrelin | Leptin - therapeutic use | Leptin - genetics | Receptor, Melanocortin, Type 4 - agonists | Recombinant Proteins - pharmacology | Obesity - metabolism | Randomized Controlled Trials as Topic | Serotonin Receptor Agonists - therapeutic use | Animals | Hypothalamus - metabolism | Energy Metabolism | Peroxisome Proliferator-Activated Receptors - drug effects | Peroxisome Proliferator-Activated Receptors - metabolism | Receptors, G-Protein-Coupled - antagonists & inhibitors | Serotonin 5-HT2 Receptor Agonists | Anti-Obesity Agents - pharmacology
Journal Article
Acta Pharmaceutica Sinica B, ISSN 2211-3835, 03/2019, Volume 9, Issue 2, pp. 220 - 236
Obesity is increasing in an alarming rate worldwide, which causes higher risks of some diseases, such as type 2 diabetes, cardiovascular diseases, and cancer.... 
Beige cells | Obesity | Brown adipose tissue | Thermogenesis | Uncoupling protein 1 | MITOCHONDRIAL BIOGENESIS | LIVER-X RECEPTOR | VITAMIN-D-RECEPTOR | BROWN ADIPOSE-TISSUE | UNCOUPLING PROTEIN GENE | DIET-INDUCED OBESITY | BODY-WEIGHT | ENERGY-EXPENDITURE | ACTIVATED-RECEPTOR | PHARMACOLOGY & PHARMACY | RETINOIC-ACID-RECEPTOR | RAR, RA receptor | Cidea, cell death-inducing DNA fragmentation factor α-like effector A | RXR, retinoid X receptor | CRE, cAMP response element | OXPHOS, oxidative phosphorylation | enhancer binding protein α | PXR, pregnane X receptor | β3-AR, β3-adrenergic receptor | HFD, high fat diet | TMEM26, transmembrane protein 26 | PGC-1α, peroxisome proliferator-activated receptor γ coactivator 1-α | TRPs, transient receptor potential cation channels | PPARs, peroxisome proliferator-activated receptors | PRDM16, PR domain containing 16 | SNS, sympathetic nervous system | UCP1, uncoupling protein 1 | FGF21, fibroblast growth factor 21 | WAT, white adipose tissue | AKT, protein kinase B | FAS, fatty acid synthase | TFAM, mitochondrial transcription factor A | VDR, vitamin D receptor | ERE, estrogen response element | Dio2, iodothyronine deiodinase type 2 | MAPK, mitogen-activated protein kinase | PKA, protein kinase A | PPREs, peroxisome proliferator response elements | VDRE, VDR response elements | CRABP-II, cellular RA binding protein type II | PTP1B, protein-tyrosine phosphatase 1B | PET-CT, positron emission tomography combined with computed tomography | AMPK, AMP-activated protein kinase | Review | EBPα, CCAAT | BMP8b, bone morphogenetic protein 8b | cAMP, cyclic adenosine monophosphate | SIRT1, silent mating type information regulation 2 homolog 1 | PDEs, phosphodiesterases | BA, bile acids | ATP, adenosine triphosphate | GPCRs, G protein-coupled receptors | RA, retinoic acid | RMR, resting metabolic rate | BAT, brown adipose tissue | LXR, liver X receptors | ERs, estrogen receptors | RARE, RA response element | cGMP, cyclic guanosine monophosphate | ALDH9, aldehyde dehydrogenase 9 | CLA, cis-12 conjugated linoleic acid
Journal Article
Circulation Research, ISSN 0009-7330, 06/2011, Volume 108, Issue 12, pp. 1448 - 1458
.... OBJECTIVE:To determine the role of β3-adrenergic receptors (β3-ARs), eNOS activation, and NO metabolites... 
cardioprotection | exercise | nitric oxide | nitrite | β3-adrenergic receptor | nitrosothiol
Journal Article
Journal Article
Biochimica et biophysica acta. Molecular and cell biology of lipids, ISSN 1388-1981, 2010, Volume 1801, Issue 9, pp. 1048 - 1055
Activation of β-adrenergic receptors (AR) in adipocytes triggers acute changes in metabolism that can alter patterns of gene expression... 
P38 | JNK | Ceramide | Inflammation | β3-adrenergic receptor | Free fatty acid | Lipolysis | Hormone sensitive lipase
Journal Article
Journal Article
Biochemical Journal, ISSN 0264-6021, 12/2009, Volume 424, Issue 3, pp. 399 - 410
.... Stimulation of 3T3-L1 adipocytes with insulin or the β3-adrenergic receptor agonist CL316243 (termed CL... 
Caveolin-1 | adrenergic receptor | Phosphodiesterase 3 (PDE3) | Adipocyte | Protein kinase A (PKA) | Insulin
Journal Article
Cardiology, ISSN 0008-6312, 04/2018, Volume 139, Issue 4, pp. 234 - 244
Septic shock with low cardiac output is very common in children. However, the mechanism underlying myocardial depression is unclear. The role of β3-AR in the... 
Original Research | Myocardial depression | Septic shock | ß3-Adrenergic receptor | Ca2+ transient | Rat | β3-Adrenergic receptor
Journal Article
Journal Article